tirzepatide 1.5 mg Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Tirzepatide – 5mg – Prime
Description
For patients considering semaglutide or already taking it, this information is critical
The two doses most studied are 0.25 mg and 0.5 mg, taken once daily as an oral tablet
If patients are currently taking other diabetic medications, dose adjustments may be necessary to mitigate the risk of hypoglycemia
Therefore decreasing appetite and having a sense of feeling full (much like after you have a meal)
[DOI] [PubMed] [Google Scholar] 514.Gao W, et al
